COMP <GO>
AVR vs ENOV // ENTERPRISE SCALE & MARKET CAP
Anteris Technologies Global Corp. (NASDAQ) VS. Enovis Corporation (NYSE) • 15-METRIC TALLY: AVR 1
— ENOV 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ENOV
LAST: $6.42 (+5.25%) • MKT CAP: $625.9M
market-cap
$625.9M
LAST: $22.81 (+4.11%) • MKT CAP: $1.32B
market-cap
$1.32B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVR VS. ENOV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVR | ENOV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.30% | 59.80% | +10.50 | AVR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -32.70% | -2.30 | ENOV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.74% | 1.51% | -14.25 | ENOV | /fcf-yield <GO> |
| Operating Margin | -60.00% | -50.00% | -10.00 | ENOV | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -52.70% | -7.30 | ENOV | /net-margins <GO> |
| Revenue Growth (YoY) | -29.20% | 6.70% | -35.90 | ENOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | ENOV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.3 | 48.3 | -6.98 | ENOV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $625.9M | $1.32B | -$689.5M | ENOV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVR REV | ENOV REV | AVR GROSS % | ENOV GROSS % | AVR FCF | ENOV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.9M | $2.25B | 70.3% | 59.8% | -$79.8M | $19.9M |
| FY 2024 | $2.7M | $2.11B | 46.8% | 56.0% | -$63.5M | -$67.2M |
| FY 2023 | — | $1.71B | — | — | — | $135.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVR // BETA —
ENOV // BETA —